Uric acid and the cardiovascular profile of African and Caucasian men

Journal of Human Hypertension

Volumn 24, Issue 10, 2010, Pages 639-645

  Palmer, I M ^a   Schutte, A E ^a   Huisman, H W ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

African population; cardiovascular disease; Caucasian population; metabolic syndrome; uric acid

Indexed keywords

TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; RACE DIFFERENCE; VASCULAR RESISTANCE; WAIST CIRCUMFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; TRIGLYCERIDES; URIC ACID; WAIST CIRCUMFERENCE;

EID: 77956882721     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.1     Document Type: Article

References (39)

1. Bazzano LA, He J, Whelton PK. Blood pressure in westernized and isolated populations. In: Lip G, Hall J (eds). Comprehensive Hypertension. Elsevier: New York, NY, 2007, pp 21-30.
2. Ince H, Nienaber CA. Diagnosis and management of patients with aortic dissection. Heart 2007; 93: 266-270.
3. Gagliardi ACM, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009; 202: 11-17.
4. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Followup Study, 1971-1992. JAMA 2000; 283: 2404-2410.
5. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-996.
6. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE et al. Serum uric acid predicts incident hypertension in a Biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006; 48: 1037-1042.
7. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28 613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008; 125: 232-239.
8. Feig DI, Kang D, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
9. Miyatake N, Kogashiwa M, Wang D, Kira S, Yamasato T, Fujii M. The relation between visceral adipose tissue accumulation and biochemical tests in university students. Acta Med Okayama 2005; 59: 129-134.
10. Cohn GS, Kittleson MM, Blumenthal RS. Toward an improved diagnosis of the metabolic syndrome: other clues to the presence of insulin resistance. Am J Hypertens 2005; 18: 1099-1103.
11. Waring WS, Esmail S. How should serum uric acid concentrations be interpreted in patients with hypertension? Curr Hypertens Rev 2005; 1: 89-95.
12. Palmer IM, Schutte AE, Huisman HW, Van Rooyen JM, Schutte R, Malan L et al. A comparison of uric acid levels in black African vs Caucasian women from South Africa: the POWIRS study. Ethn Dis 2007; 17: 676-681.
13. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4(9): doi:10.1186/1471-2458-4-9.
14. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002; 2: 126-130.
15. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371: 915-922.
16. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005; 112: 3562-3568.
17. Mack R, Skurnick B, Sterling-Jean Y, Pedra-Nobre M, Bigg D. Fasting insulin levels as a measure of insulin resistance in American blacks. J Appl Res 2004; 4: 90-94.
18. Norton K, Olds T (eds). Anthropometrica: A Textbook of Body Measurements for Sports and Health Courses. UNSW Press: Sydney, 1996.
19. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165: 2098-2104.
20. Reimann M, Schutte AE, Malan L, Huisman HW, Malan NT. Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis. Atherosclerosis 2008; 197: 638-645.
21. Reimann M, Schutte AE, Schwarz PE. Insulin resistance-the role of ethnicity: evidence from Caucasian and African cohorts. Horm Metab Res 2007; 39: 853-857.
22. Lu B, Zhou J, Waring ME, Parker DR, Eaton CB. Abdominal obesity and peripheral vascular disease in men and women: A comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis 2009; 208(1): 253-257.
23. Dagenais GR, Yi Q, Mann JFE, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149: 54-60.
24. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005; 52: 283-289.
25. Dyer AR, Liu K, Walsh M, Kiefe C, Jacobs Jr DR, Bild DE. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. J Hum Hypertens 1999; 13: 13-21.
26. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang D et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899-906.
27. Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009; 30: 96-116.
28. Schwarzmeier JD, Mark TL, Moser K, Lujf A. Fructose induced hyperuricemia. Res Exp Med 1974; 162: 341-346.
29. Franklin SS. Beyond blood pressure: arterial stiffness as a new biomarker of cardiovascular disease. J Am Soc Hypertens 2008; 2: 140-151.
30. Touyz RM. Vascular remodeling, retinal arteries, and hypertension. Hypertension 2007; 50: 603-604.
31. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275.
32. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Neph 2005; 25: 425-433.
33. Kanellis J,Watanabe S, Li JH, Kang DH, Li P, Nakagawa T et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293.
34. Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008; 295: C1183-C1190.
35. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466-1471.
36. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clinica Chimica Acta 2006; 368: 33-47.
37. Lin S, Tsai D, Hsu S. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 2006; 69: 512-516.
38. Tavil Y, Kaya MG, Oktar SÖ , Sen N, Okyay K, Yazỳcỳ HU et al. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008; 197: 159-163.
39. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-447.